Congenital lung lesions-underlying molecular mechanisms

Seminars in Pediatric Surgery

Volumn 19, Issue 3, 2010, Pages 171-179

  Correia Pinto, Jorge ^a,b   Gonzaga, Sílvia ^a   Huang, Yadi ^c   Rottier, Robbert ^c  

^a UNIVERSITY OF MINHO   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Congenital cystic adenomatoid malformation; Congenital lobar emphysema; Congenital lung diseases; Congenital pulmonary airway malformation; Lung development; Pulmonary sequestration

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; COLLAGENASE; DICKKOPF 1 PROTEIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 4; FORKHEAD TRANSCRIPTION FACTOR; HOX B5 PROTEIN; HOX PROTEIN; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEOGLYCAN; RETINAL DEHYDROGENASE; RETINAL DEHYDROGENASE 2; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; SONIC HEDGEHOG PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR T BET; TRANSCRIPTION FACTOR TBX4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BIOTRANSFORMATION; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CYSTIC ADENOMATOID MALFORMATION; ENDODERM; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE ACTIVATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GESTATIONAL AGE; HEART; HISTOPATHOLOGY; HOX GENE; HUMAN; LUNG AGENESIS; LUNG ALVEOLUS EPITHELIUM; LUNG CYST; LUNG DEVELOPMENT; LUNG EMPHYSEMA; LUNG LESION; LUNG SEQUESTRATION; MESENCHYME; MOLECULAR BIOLOGY; MORPHOGENESIS; NOTOCHORD; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRACHEOBRONCHIAL TREE; TRACHEOESOPHAGEAL FISTULA; BRONCHOGENIC CYST; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL; DEVELOPMENTAL DISABILITIES; FEMALE; FETUS DEVELOPMENT; GENETIC PREDISPOSITION; GENETICS; INFANT; LUNG; MALE; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY EMPHYSEMA; RESPIRATORY SYSTEM ABNORMALITIES; RISK ASSESSMENT;

BRONCHOGENIC CYST; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL; DEVELOPMENTAL DISABILITIES; FEMALE; FETAL DEVELOPMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MALE; MOLECULAR BIOLOGY; PULMONARY EMPHYSEMA; RESPIRATORY SYSTEM ABNORMALITIES; RISK ASSESSMENT;

EID: 77953941536     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2010.03.003     Document Type: Article

References (67)

1. Adzick N.S. Management of fetal lung lesions. Clin Perinatol 2009, 36:363-376.
2. Azizkhan R.G., Crombleholme T.M. Congenital cystic lung disease: Contemporary antenatal and postnatal management. Pediatr Surg Int 2008, 24:643-657.
3. Roth-Kleiner M., Post M. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol 2005, 40:113-134.
4. Cardoso W.V., Lü J. Regulation of early lung morphogenesis: Questions, facts and controversies. Development 2006, 133:1611-1624.
5. Maeda Y., Davé V., Whitsett J.A. Transcriptional control of lung morphogenesis. Physiol Rev 2007, 87:219-244.
6. Miura T. Modeling lung branching morphogenesis. Curr Top Dev Biol 2008, 81:291-310.
7. Chen F., Desai T.J., Qian J., et al. Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction. Development 2007, 134:2969-2979.
8. Mendelsohn C., Lohnes D., Decimo D., et al. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994, 120:2749-2771.
9. Sakiyama J., Yamagishi A., Kuroiwa A. Tbx4-Fgf10 system controls lung bud formation during chicken embryonic development. Development 2003, 130:1225-1234.
10. Krumlauf R. Hox genes in vertebrate development. Cell 1994, 78:191-201.
11. Volpe M.V., Vosatka R.J., Nielsen H.C. Hoxb-5 control of early airway formation during branching morphogenesis in the developing mouse lung. Biochim Biophys Acta 2000, 1475:337-345.
12. Gontan C., de Munck A., Vermeij M., et al. Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation. Dev Biol 2008, 317:296-309.
13. Keijzer R., van Tuyl M., Meijers C., et al. The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development. Development 2001, 128:503-511.
14. Wan H., Dingle S., Xu Y., et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem 2005, 280:13809-13816.
15. van Tuyl M., Groenman F., Wang J., et al. Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. Dev Biol 2007, 303:514-526.
16. Metzger R.J., Klein O.D., Martin G.R., et al. The branching programme of mouse lung development. Nature 2008, 453:745-750.
17. De Langhe S.P., Reynolds S.D. Wnt signaling in lung organogenesis. Organogenesis 2008, 4:100-108.
18. Santos M., Moura R.S., Gonzaga S., et al. Embryonic essential myosin light chain regulates fetal lung development in rats. Am J Respir Cell Mol Biol 2007, 37:330-338.
19. Santos M., Bastos P., Gonzaga S., et al. Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia. Pediatr Res 2006, 59:531-537.
20. Nogueira-Silva C., Santos M., Baptista M.J., et al. IL-6 is constitutively expressed during lung morphogenesis and enhances fetal lung explant branching. Pediatr Res 2006, 60:530-536.
21. Nogueira-Silva C., Moura R.S., Esteves N., et al. Intrinsic catch-up growth of hypoplastic fetal lungs is mediated by interleukin-6. Pediatr Pulmonol 2008, 43:680-689.
22. Jesudason E.C., Smith N.P., Connell M.G., et al. Developing rat lung has a sided pacemaker region for morphogenesis-related airway peristalsis. Am J Respir Cell Mol Biol 2005, 32:118-127.
23. Gonzaga S., Henriques-Coelho T., Davey M., et al. Cystic adenomatoid malformations are induced by localized FGF10 overexpression in fetal rat lung. Am J Respir Cell Mol Biol 2008, 39:346-355.
24. Wan H., Luo F., Wert S.E., et al. Krüppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 2008, 135:2563-2572.
25. Burri P.H. Lung development and pulmonary angiogenesis. Lung Development 1999, Oxford University Press, New York, 122. C. Gaultier, J. Bourbon, M. Post (Eds.).
26. Wilkinson G.A., Schittny J.C., Reinhardt D.P., et al. Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. Dev Dyn 2008, 237:2220-2234.
27. Bourbon J., Boucherat O., Chailley-Heu B., et al. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Rev 2005, 57:38-46.
28. Laberge J.M., Flageole H., Pugash D., et al. Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: A Canadian experience. Fetal Diagn Ther 2001, 16:178-186.
29. Stocker J.T. Congenital pulmonary airway malformation: A new name and expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology 2002, 41(suppl):424-431.
30. Stocker J.T., Madewell J.E., Drake R.M. Congenital cystic adenomatoid malformation of the lung: Classification and morphologic spectrum. Hum Pathol 1997, 8:155-171.
31. Stocker J.T. Congenital and developmental diseases. Pulmonary Pathology 1994, Springer, New York, p 155. O.H. Dail, S.P. Hammar (Eds.).
32. Adzick N.S., Harrison M.R., Glick P.L., et al. Fetal cystic adenomatoid malformation: Prenatal diagnosis and natural history. J Pediatr Surg 1985, 20:483-488.
33. Laje P., Liechty K.W. Postnatal management and outcome of prenatally diagnosed lung lesions. Prenat Diagn 2008, 28:612-618.
34. Morotti R.A., Cangiarella J., Gutierrez M.C., et al. Congenital cystic adenomatoid malformation of the lung (CCAM): Evaluation of the cellular components. Hum Pathol 1999, 30:618-625.
35. Cass D.L., Quinn T.M., Yang E.Y., et al. Increased cell proliferation and decreased apoptosis characterize congenital cystic adenomatoid malformation of the lung. J Pediatr Surg 1998, 33:1043-1046.
36. Volpe M.V., Pham L., Lessin M., et al. Expression of Hoxb-5 during human lung development and in congenital lung malformations. Birth Defects Res A Clin Mol Teratol 2003, 67:550-556.
37. Jancelewicz T., Nobuhara K., Hawgood S. Laser microdissection allows detection of abnormal gene expression in cystic adenomatoid malformation of the lung. J Pediatr Surg 2008, 43:1044-1051.
38. Liechty K.W., Crombleholme T.M., Quinn T.M., et al. Elevated platelet-derived growth factor-B in congenital cystic adenomatoid malformations requiring fetal resection. J Pediatr Surg 1999, 34:805-810.
39. Volpe M.V., Chung E., Ulm J.P., et al. Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation. Am J Physiol Lung Cell Mol Physiol 2009, 297:L143-L152.
40. Fromont-Hankard G., Philippe-Chomette P., Delezoide A.L., et al. Glial cell-derived neurotrophic factor expression in normal human lung and congenital cystic adenomatoid malformation. Arch Pathol Lab Med 2002, 126:432-436.
41. Wagner A.J., Stumbaugh A., Tigue Z., et al. Genetic analysis of congenital cystic adenomatoid malformation reveals a novel pulmonary gene: Fatty acid binding protein-7 (brain type). Pediatr Res 2008, 64:11-16.
42. Haunerland N.H., Spener F. Fatty acid-binding proteins-Insights from genetic manipulations. Prog Lipid Res 2004, 43:328-349.
43. Simonet W.S., DeRose M.L., Bucay N., et al. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc Natl Acad Sci U S A 1995, 92:12461-12465.
44. Clark J.C., Tichelaar J.W., Wert S.E., et al. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol 2001, 280:L705-L715.
45. White A.C., Xu J., Yin Y., et al. FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development 2006, 133:1507-1517.
46. Miura T., Hartmann D., Kinboshi M., et al. The cyst-branch difference in developing chick lung results from a different morphogen diffusion coefficient. Mech Dev 2009, 126:160-172.
47. Sakiyama J., Yokouchi Y., Kuroiwa A. Coordinated expression of Hoxb genes and signaling molecules during development of the chick respiratory tract. Dev Biol 2000, 227:12-27.
48. Stacher E., Ullmann R., Halbwedl I., et al. Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible pre-neoplasia for pulmonary adenocarcinoma in childhood: A genetic analysis. Hum Pathol 2004, 35:565-570.
49. Cass D.L., Crombleholme T.M., Howell L.J., et al. Cystic lung lesions with systemic arterial blood supply: A hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration. J Pediatr Surg 1997, 32:986-990.
50. MacSweeney F., Papagiannopoulos K., Goldstraw P., et al. An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation. Am J Surg Pathol 2003, 27:1139-1146.
51. Guo H., Cajaiba M.M., Borys D., et al. Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation. Hum Pathol 2008, 38:1772-1778.
52. Mendeloff E.N. Sequestrations, congenital cystic adenomatoid malformations, and congenital lobar emphysema. Semin Thorac Cardiovasc Surg 2004, 16:209-214.
53. Wesley J.R., Heidelberger K.P., DiPietro M.A., et al. Diagnosis and management of congenital cystic disease of the lung in children. J Pediatr Surg 1986, 21:202-207.
54. Adzick N.S., Farmer D.L. Cysts of the lungs and mediastinum. Pediatric Surgery 2006, vol 1. Mosby Inc, Philadelphia, chap 61. 6th edn. J.L. Grosfeld, J.A. O'Neill, A.G. Coran, E.W. Fonkalsrud (Eds.).
55. Pinkerton H.J., Oldham K.T. Lung. Principles and Practice of Pediatric Surgery 2005, vol 2. Lippincott Williams & Wilkins, Philadelphia, chap 61. K.T. Oldham, P.M. Colombani, R. Foglia (Eds.).
56. Corbett H.J., Humphrey G.M. Pulmonary sequestration. Paediatr Respir Rev 2004, 5:59-68.
57. Azizkhan R.G., Crombleholme T.M. Congenital cystic lung disease: Contemporary antenatal and postnatal management. Pediatr Surg Int 2008, 24:643-657.
58. DeParedes C.G., Pierce W.S., Johnson D.G. Pulmonary sequestration in infants and children: A 20-year experience and review of the literature. J Pediatr Surg 1970, 5:136-147.
59. Luck S.R., Reynolds M., Raffensperger J.G. Congenital bronchopulmonary malformations. Curr Probl Surg 1986, 23:245-314.
60. Williams H.J., Johnson K.J. Imaging of congenital cystic lung lesions. Paediatr Respir Rev 2002, 3:120-127.
61. Quinton A.E., Smoleniec J.S. Congenital lobar emphysema-The disappearing chest mass: Antenatal ultrasound appearance. Ultrasound Obstet Gynecol 2001, 17:169-171.
62. Pariente G., Aviram M., Landau D., et al. Prenatal diagnosis of congenital lobar emphysema: Case report and review of the literature. J Ultrasound Med 2009, 28:1081-1084.
63. Laberge J.M., Puligandla P., Flageole H. Asymptomatic congenital lung malformations. Semin Pediatr Surg 2005, 14:16-33.
64. Olutoye O.O., Coleman B.G., Hubbard A.M., et al. Prenatal diagnosis and management of congenital lobar emphysema. J Pediatr Surg 2000, 35:792-795.
65. Langston C. New concepts in the pathology of congenital lung malformations. Semin Pediatr Surg 2003, 12:17-37.
66. McAdams H.P., Kirejczyk W.M., Rosado-de-Christenson M.L., et al. Bronchogenic cyst: Imaging features with clinical and histopathologic correlation. Radiology 2000, 217:441-446.
67. de Perrot M., Pache J.C., Spiliopoulos A. Carcinoma arising in congenital lung cysts. J Thorac Cardiovasc Surg 2001, 49:184-185.